Dexter Formulation Private Limited, a active private limited company, was established on 23 April 2009 in Mayialduthurai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33110TN2009PTC071429. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Dexter Formulations Private Limited. It upholds a active non-compliant status. Its leadership includes Sivaraman Vijay (Managing Director), Rajamohan Yamuna (Director). Past directors included Sivaraman Vijay, Henry Doss Maria Gnanaprakasam, Sivaraman Madhumitha. It holds ₹2.60 M open charges and no settled loans. Its latest AGM occurred on 30 August 2024, with the balance sheet filed on 31 March 2024. It is based at Old No.60, New No.50 Senbaga Street, Besant Nagar, Mayialduthurai, Tamil Nadu, 609001.
U33110TN2009PTC071429
071429
23 April 2009
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Dexter Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sivaraman Vijay | Managing Director | 23 Apr 2009 | Current |
| Rajamohan Yamuna | Director | 31 Oct 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2015 | Past |
| Pramod Abcsdd | Director | 14 Nov 2018 | Past |
| Pramod Abcsdd | Director | 31 Oct 2014 | Past |
| Pramod Abcsdd | Managing Director | 01 Oct 2015 | Past |
| Pramod Abcsdd | Director | 01 Oct 2015 | Past |
| Pramod Abcsdd | Director | 01 Oct 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dexter Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.05% increase. The company also saw a substantial improvement in profitability, with a 36.41% increase in profit. The company's net worth Soared by an impressive increase of 58.72%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Dexter Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2024 | Indian Bank | ₹2.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dexter Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dexter Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dexter Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dexter Formulation Private Limited last Annual general meeting of members was held on 30 Aug 2024 as per latest MCA records. was documented.
The activity A charge with Indian Bank amounted to Rs. 2.60 M with Charge ID 100925753 was registered on 16 May 2024. was completed.
Progress on Dexter Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Rajamohan Yamuna was appointed as a Director was appointed as a Director on 31 Oct 2014 & has been associated with this company since 11 years 29 days . was recorded as a recent event.
Sivaraman Vijay was appointed as a Managing Director was appointed as a Managing Director on 23 Apr 2009 & has been associated with this company since 16 years 7 months . was recorded as a recent event.
Dexter Formulation Private Limited was registered on 23 Apr 2009 with Roc Chennai & aged 16 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Dexter Formulation Private Limited is U33110TN2009PTC071429.
Dexter Formulation Private Limited is headquartered at Old No.60, New No.50 Senbaga Street, Besant Nagar, Mayialduthurai, Tamil Nadu, 609001.
Dexter Formulation Private Limited was incorporated on 23 April 2009.
The current directors of Dexter Formulation Private Limited are
The primary industry of Dexter Formulation Private Limited is Manufacturing.
Dexter Formulation Private Limited is unlisted.
The authorized capital of Dexter Formulation Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dexter Formulation Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX